Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,290 | 447 | 97.9% |
| Education | $134.94 | 5 | 1.8% |
| Consulting Fee | $19.76 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,025 | 84 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $902.58 | 51 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $767.79 | 43 | $0 (2024) |
| Amgen Inc. | $577.61 | 33 | $0 (2024) |
| GlaxoSmithKline, LLC. | $535.13 | 37 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $395.43 | 27 | $0 (2023) |
| Gilead Sciences, Inc. | $334.09 | 21 | $0 (2020) |
| Radius Health, Inc. | $321.93 | 13 | $0 (2020) |
| Lilly USA, LLC | $308.94 | 20 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $242.41 | 14 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $276.90 | 17 | PFIZER INC. ($149.57) |
| 2023 | $857.61 | 47 | PFIZER INC. ($249.96) |
| 2022 | $179.19 | 9 | E.R. Squibb & Sons, L.L.C. ($43.28) |
| 2021 | $57.49 | 2 | PFIZER INC. ($57.49) |
| 2020 | $379.68 | 19 | Lilly USA, LLC ($57.30) |
| 2019 | $1,776 | 99 | Amgen Inc. ($217.09) |
| 2018 | $1,689 | 100 | AstraZeneca Pharmaceuticals LP ($244.07) |
| 2017 | $2,229 | 160 | AstraZeneca Pharmaceuticals LP ($403.66) |
All Payment Transactions
453 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: VACCINES | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: VACCINES | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: VACCINES | ||||||
| 08/08/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $28.02 | General |
| Category: Bone Health | ||||||
| 06/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Bone Health | ||||||
| 05/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: VACCINES | ||||||
| 05/03/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: VACCINES | ||||||
| 04/08/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: VACCINES | ||||||
| 04/07/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: PAIN | ||||||
| 04/02/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: VACCINES | ||||||
| 03/23/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: VACCINES | ||||||
| 02/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Respiratory | ||||||
| 01/24/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: VACCINES | ||||||
| 01/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: VACCINES | ||||||
| 12/15/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: VACCINES | ||||||
| 11/14/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: VACCINES | ||||||
| 11/14/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.13 | General |
| 10/26/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: PAIN | ||||||
| 10/23/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: VACCINES | ||||||
| 10/19/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: PAIN | ||||||
| 10/17/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 982 | 2,546 | $446,224 | $141,343 |
| 2022 | 16 | 1,034 | 2,782 | $448,892 | $147,474 |
| 2021 | 14 | 1,042 | 3,248 | $345,982 | $177,898 |
| 2020 | 18 | 1,184 | 3,542 | $325,177 | $141,627 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 358 | 660 | $227,700 | $62,165 | 27.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 139 | 180 | $87,300 | $23,635 | 27.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 12 | 1,200 | $40,800 | $22,223 | 54.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 94 | 94 | $12,502 | $7,126 | 57.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 24 | 24 | $13,608 | $6,765 | 49.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 90 | 102 | $24,990 | $6,183 | 24.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $14,304 | $3,566 | 24.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 21 | 21 | $12,411 | $3,414 | 27.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 100 | 103 | $3,090 | $3,028 | 98.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 30 | 33 | $4,752 | $1,470 | 30.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 24 | $720.00 | $705.60 | 98.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 18 | $2,772 | $645.45 | 23.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 25 | $975.00 | $312.75 | 32.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 27 | 30 | $300.00 | $102.30 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 370 | 700 | $241,500 | $67,099 | 27.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 120 | 180 | $87,300 | $25,772 | 29.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 16 | 1,320 | $44,880 | $22,362 | 49.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 135 | $33,075 | $9,180 | 27.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 101 | 102 | $6,630 | $6,507 | 98.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 16 | 16 | $9,072 | $4,174 | 46.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 103 | 104 | $3,120 | $3,114 | 99.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 16 | 16 | $2,288 | $2,105 | 92.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 39 | 43 | $6,192 | $1,948 | 31.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $4,917 | $1,338 | 27.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 20 | 26 | $4,004 | $1,313 | 32.8% |
About Dr. Marlon Decastro, M.D
Dr. Marlon Decastro, M.D is a Internal Medicine healthcare provider based in Santa Rosa, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780643270.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marlon Decastro, M.D has received a total of $7,445 in payments from pharmaceutical and medical device companies, with $276.90 received in 2024. These payments were reported across 453 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($7,290).
As a Medicare-enrolled provider, Decastro has provided services to 4,242 Medicare beneficiaries, totaling 12,118 services with total Medicare billing of $608,343. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Santa Rosa, CA
- Active Since 03/22/2006
- Last Updated 03/07/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1780643270
Products in Payments
- PREVNAR 20 (Biological) $328.54
- SYMBICORT (Drug) $322.50
- Tymlos (Biological) $321.93
- XARELTO (Drug) $315.19
- JARDIANCE (Drug) $281.55
- STIOLTO RESPIMAT (Drug) $273.35
- Prolia (Biological) $256.08
- FARXIGA (Drug) $253.20
- NUEDEXTA (Drug) $235.54
- EVENITY (Biological) $229.55
- TRELEGY ELLIPTA (Drug) $224.48
- BEVESPI AEROSPHERE (Drug) $221.31
- PREVNAR - 13 (Biological) $183.02
- TRULICITY (Drug) $164.82
- TOUJEO (Drug) $157.31
- ENTRESTO (Drug) $140.01
- LYRICA (Drug) $139.83
- CHANTIX (Drug) $125.13
- BREO (Drug) $121.23
- Ozempic (Drug) $117.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Santa Rosa
Zeyad Kanaan, M.d, M.D
Internal Medicine — Payments: $230,599
Rajveer Sangera, Do, DO
Internal Medicine — Payments: $42,357
Pamela Maur, M.d, M.D
Internal Medicine — Payments: $41,731
Kent Matsuda, M.d, M.D
Internal Medicine — Payments: $9,102
Sara Keck, Md, MD
Internal Medicine — Payments: $7,051
Neil Levin, M.d, M.D
Internal Medicine — Payments: $6,990